CoAxia
Medical device company engaged in the R&D of therapy and treatment solutions for cerebral ischemia.
Launch date
Employees
Market cap
-
Enterprise valuation
$20—30m (Dealroom.co estimates Mar 2011.)
Maple Grove Minnesota (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$17.6m | Series B | ||
$11.0m | Series C | ||
N/A | $11.5m | Series C | |
$21.5m | Series D | ||
N/A | $5.0m | Early VC | |
N/A | Acquisition | ||
Total Funding | $66.6m |
Recent News about CoAxia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.